Webinar series


This webinar originally took place on Tuesday 26 November 2019. You will be sent the recording, presentation slides and certificate once payment has been made. The webinar recording will be available to view until Tuesday 11 January 2022.


Individual fee £35 or all 3 webinars in the series for £99

Other webinars in the Care of the Older Person series:

Falls and Frailty

Audience: GPs (all grades)

Care of the Older Person Webinar Series: Dementia

This webinar will enable GPs and Primary Care healthcare professionals to improve the quality of evidence based dementia care.

Join this webinar to learn and ask an expert your questions about:

  • Prevention: risk reduction & ‘high risk groups’
  • Diagnosing Dementia – DiADem Tool

After this webinar you will:

  • Recognise which conditions are associated with an increased risk for dementia
  • Be aware of the interventions that can decrease risk for dementia
  • Recognise those people with mild cognitive impairment who are greater risk of progression to dementia
  • Understand how to undertake targeted “case finding” for dementia in residents of Care / Residential Homes
  • Feel more confident in using the DiADem tool to diagnose advanced dementia in people in Care Homes

Extra features

Dedicated Q&A session

30 day on-demand access to the video recording and presentation slides

 Booking this webinar will give you a 10% discount for BMJ Learning


CPD Certificate of participation

30 day access to webinar recording

 Flexible distance learning

 Watch in your own time

 1 CPD hour

 Includes speaker presentation slides

Jill Rasmussen

Jill Rasmussen

Clinical Representative for Dementia, Royal College of General Practitioners

Dr. Jill Rasmussen is a Clinician with special interest in psychiatry and neurology. Following an initial period of nine years in the NHS she worked in the pharmaceutical industry in Europe, the US and UK for ten years where she held senior positions in a number of companies with responsibility for the development of new drugs for psychiatry and neurology. She also spent two years with the Medicines Control Agency (Now the MHRA).

Since 1994, she has combined part-time clinical practice with her own independent research consultancy ( www.psi-napse.com ). In her consultancy she specialises in advising about development and medico- marketing strategy for drugs in CNS indications (includes NICE HTAs), is an advisor to venture capital groups and is a member of the Wellcome Trust Pathfinder Awards Committee.

In the NHS she has experience as a GP with Special Interest in Mental Health, Dementia and Learning Disability, as a commissioner and as representative for mental health and dementia for NHS England Team South East Region; currently she has national roles as RCGP Clinical Representative for Dementia, Advisor to Surrey Heartlands STP and to the Academic Health Science Network Kent Surrey Sussex and is Chair of the Lewy Body Society Specialist Advisory Group.

This is a unique website which will require a more modern browser to work!

Please upgrade today!